Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.44% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Sep 30, 2015
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-15-008469General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
6.16% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-18.95% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
53.34% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
87.57% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
3.44% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.61% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
-1.56% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -0.52%
- Current
- 0.44%
- Delta
- 0.96%
- Previous
- 22.83%
- Current
- 6.16%
- Delta
- -16.67%
- Previous
- -8.62%
- Current
- -18.95%
- Delta
- -10.33%
- Previous
- 53.82%
- Current
- 53.34%
- Delta
- -0.48%
- Previous
- 86.12%
- Current
- 87.57%
- Delta
- 1.45%
- Previous
- 7.56%
- Current
- 3.44%
- Delta
- -4.13%
- Previous
- 9.29%
- Current
- 9.61%
- Delta
- 0.31%
- Previous
- 3.40%
- Current
- -1.56%
- Delta
- -4.96%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Analogous To · CPIX state analogue 3 →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_INCREASED →Transitioned To · CPIX CASH_GENERATION_DECREASED →Transitioned To · CPIX GROWTH_DECREASED →Transitioned To · CPIX INVENTORY_PRESSURE_DECREASED →Transitioned To · CPIX MARGIN_INCREASED →Transitioned To · CPIX PROFITABILITY_DECREASED →Transitioned To · CPIX R_AND_D_INTENSITY_INCREASED →Transitioned To · CPIX SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.